Jakavi 5 mg

Jakavi 5 mg is a medicine authorised by Swissmedic under authorisation number 62126. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 27 December 2012 and the authorisation is valid without a time limit. ATC code L01EJ01 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 62126
  • ATC L01EJ01
  • Synthetic medicines
Authorisation data
Authorisation number62126
NameJakavi 5 mg
Full nameJakavi 5 mg, Tabletten
Authorisation holderNovartis Pharma Schweiz AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01EJ01
First authorisation27 December 2012
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Jakavi 5 mg, TablettenA27 December 2012
2Jakavi 15 mg, TablettenA27 December 2012
3Jakavi 20 mg, TablettenA27 December 2012
4Jakavi 10 mg, TablettenA10 June 2015

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
156Tablette(n)L01EJ0107.16.1.A
23 x 56Tablette(n)L01EJ0107.16.1.A
456Tablette(n)L01EJ0107.16.1.A
53 x 56Tablette(n)L01EJ0107.16.1.A
756Tablette(n)L01EJ0107.16.1.A
83 x 56Tablette(n)L01EJ0107.16.1.A
1056Tablette(n)L01EJ0107.16.1.A
113 x 56Tablette(n)L01EJ0107.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Jakavi 5 mg authorised in Switzerland?

Yes. Jakavi 5 mg is authorised by Swissmedic under authorisation number 62126, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Jakavi 5 mg have?

Jakavi 5 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Jakavi 5 mg?

The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com